Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines

Cancer Research

Volumn 58, Issue 16, 1998, Pages 3660-3667

  Johnsen, Alyssa ^a   France, John ^a   Sy, Man Sun ^a   Harding, Clifford V ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAMMA INTERFERON; GENE PRODUCT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; POLYPEPTIDE; PROTEASOME; TUMOR ANTIGEN;

ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ATP-BINDING CASSETTE TRANSPORTERS; CYSTEINE ENDOPEPTIDASES; DOWN-REGULATION; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MULTIENZYME COMPLEXES; POLYMERASE CHAIN REACTION; PROTEINS; TUMOR CELLS, CULTURED;

EID: 0032529634     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Boon, T., Cerottini, J-C., VandenEynde, B., VanderBruggen, P., and VanPel, A. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol., 12: 337-365, 1994.
2. Allison, J. P., Hurwitz, A. A., and Leach, D. R. Manipulation of costimulatory signals to enhance antitumor T-cell responses. Curr. Opin. Immunol., 7: 682-686, 1995.
3. Garrido, R, Cabrera, T., Concha, A., Glew, S., Ruiz-Cabello, F., and Stern, P. L. Natural history of HLA expression during tumour development. Immunol. Today. 14: 491-499, 1993.
4. Ferrone, S., and Marincola, F. M. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today. 16: 487-494, 1995.
5. York, I. A., and Rock, K. L. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol., 14: 369-396, 1996.
6. Groettrup, M., Soza, A., Kuckelkorn, U., and Kloetzel, P-M. Peptide antigen production by the proteasome: complexity provides efficiency. Immunol. Today, 17: 399-444, 1996.
7. Hochstrasser, M. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr. Opin. Cell Biol., 7: 215-223, 1995.
8. Löwe, J., Stock, D., Jap, B., Zwickl, P., Baumeister, W., and Huber, R. Crystal structure of the 2OS proteasome from the archaeon T. acidophilum at 3.4 resolution. Science (Washington DC), 268: 533-539, 1995.
9. Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., and Schreiber, S. L. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science (Washington DC). 268: 726-731, 1995.
10. Belich, M. P., Glynne, R. J., Senger, G., Sheer, D., and Trowsdale, J. Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins. Curr. Biol., 4: 769-776, 1994.
11. Akiyama, K., Yokota, K., Kagawa, S., Shimbara, N., Tamura, T., Akioka, A., Nothwang, H. G., Noda, C., Tanaka, K., and Ichihara, A. cDNA cloning and interferon-γ down-regulation of proteasomal subunits X and Y. Science (Washington DC), 265: 1231-1234, 1994.
12. Groettrup, M., Ruppert, T., Kuehn, L., Seeger, M., Standera, S., Koszinowski, U., and Kloetzel, P. M. The interferon-γ-inducible 11 S regulator (PA28) and the LMP2/ LMP7 subunits govern the peptide production by the 20 S proteasome in vitro. J. Biol. Chem., 270: 23808-23815, 1995.
13. Hisamatsu, H., Shimbara, N., Saito, Y., Kristensen, P., Hendil, K. B., Fujiwara, T., Takahashi, E., Tanahashi, N., Tamura, T., Ichihara, A., and Tanaka, K. Newly identified pair of proteasomal subunits regulated reciprocally by interferon γ. J. Exp. Med., 183: 1807-1816, 1996.
14. Nandi, D., Jiang, H., and Monaco, J. J. Identification of MECL-1 (LMP-IO) as the third IFN-γ-inducible proteasome subunit. J. Immunol., 156: 2361-2364, 1996.
15. Driscoll, J., Brown, M. G., Finley, D., and Monaco, J. J. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature (Lond.), 365: 262-266, 1993.
16. Gaczynska, M., Rock, K. L., and Goldberg, A. L. γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature (Lond.), 365: 254-267, 1993.
17. Arnold, D., Driscoll, J., Androlewicz, M., Hughes, E., Cresswell, P., and Spies, T. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class 1 molecules. Nature (Lond.), 360: 171-174, 1992.
18. Momburg, F., Ortiz-Navarrete, V., Neefjes, J., Goulmy, E., VandeWal, Y., Spits, H., Powis, S. J., Butcher, G. W., Howard, J. C., Walden, P., and Hammerling, G. J. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature (Lond.), 360: 174-177, 1992.
19. Yewdell, J., Lapham, C., Bacik, I., Spies, T., and Bennink, J. MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation. J Immunol., 152: 1163-1169, 1994.
20. Zhou, X., Momburg, F., Liu, T., Motal, U. M. A., Jondal, M., Hammerling, G. J., and Ljunggren, H-G. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2-and LMP7-deficient cells. Eur. J. Immunol., 24: 1863-1868, 1994.
21. Fehling, H. J., Swat, W., Laplace, C., Kuhn, R., Rajewsky, K., Muller, U., and Boehmer, H. v. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science (Washington DC), 265: 1234-1237, 1994.
22. VanKaer, L., Ashton-Rickardt, P. G., Eichelberger, M., Gaczynska, M., Nagashima, K., Rock, K. L., Goldberg, A. L., Doherty, P. C., and Tonegawa, S. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity, 1: 533-541, 1994.
23. Larsen, F., Solheim, J., Kristensen, T., Kolsto, A. B., and Prydz, H. A tight cluster of five unrelated human genes on chromosome 16q22.1. Hum. Mol. Genet., 2: 1589-1595, 1993.
24. Jentsch, S., and Schlenker, S. Selective protein degradation, a journey's end within the proteasome. Cell, 82: 881-884, 1995.
25. Chu-Ping, M., Slaughter, C. A., and DeMartino, G. N. Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (Macropain). J. Biol. Chem., 267: 10515-10523, 1992.
26. Dubiel, W., Pratt, G., Ferrell, K., and Rechsteiner, M. Purification of an 11 S regulator of the multicatalytic protease. J. Biol. Chem., 267: 22369-22377, 1992.
27. Ahn, J. Y., Tanahashi, N., Akiyama, K-y., Hisamatsu, H., Noda, C., Tanaka, K., Chung, C. H., Shibmara, N., Willy, P. J., Mott, J. D., Slaughter, C. A., and Demartino, G. N. Primary structures of two homologous subunits of PA28, a γ-interferon-inducible protein activator of the 2OS proteasome. FEBS Lett., 366: 37-42, 1995.
28. Realini, C., Dubiel, W., Pratt, G., Ferrell, K., and Rechsteiner, M. Molecular cloning and expression of a γ-interferon-inducible activator of the multicatalytic protease. J. Biol. Chem., 269: 20727-20732, 1994.
29. Mott, J. D., Pramanik, B. C., Moomaw, C. R., Afendis, S. J., DeMartino, G. N., and Slaughter, C. A. PA28, an activator of the 2OS proteasome, is composed of two nonidentical but homologous subunits. J. Biol. Chem., 269: 31466-31471, 1994.
30. Gray, C. W., Slaughter, C. A., and DeMartino, G. N. PA28 activator protein forms regulatory caps on proteasome stacked rings. J. Mol. Biol., 236: 7-15, 1994.
31. Dick, T. P., Ruppert, T., Groettrup, M., Kloetzel, P. M., Kuehn, L., Koszinowski, U. H., Stevanovic, S., Schild, H., and Rammensee, H-G. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell, 86: 253-262, 1996.
32. Groettrup, M., Soza, A., Eggers, M., Kuehn, L., Dick, T. P., Schild, H., Rammensee, H-G., Koszinowski, U. H., and Kloetzel, P-M. A role for the proteasome regulator PA28α in antigen presentation. Nature (Lond.), 381: 166-168, 1996.
33. Chen, H. L., Gabrilovich, D., Tampe, R., Girgis, K. R., Nadaf, S., and Carbone, D. P. A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer. Nat. Genet., 13: 210-213, 1996.
34. Maeurer, M. J., Gollin, S. M., Storkus, W. J., Swaney, W., Karbach, J., Martin, D., Castelli, C., Salter, R., Knuth, A., and Lotze, M. T. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6. Clin. Cancer Res., 2: 641-652, 1996.
35. Korkolopoulou, P., Kaklamanis, L., Pezzella, F., Harris, A. L., and Gatter, K. C. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. Br. J. Cancer, 73: 148-153, 1996.
36. Keating, P. J., Cromme, V. V., Duggan-Keen, M., Snijders, P. J. F., Walboomers, J. M. M., Hunter, R. D., Dyer, P. A., and Stern, P. L. Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-I expression. Br. J. Cancer. 72: 405-411, 1995.
37. Singal, D. P., Ye, M., Ni, J., and Snider, D. P. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines. Immunol. Lett., 50: 149-154, 1996.
38. Seliger, B., Hohne, A., Knuth, A., Bernhard, H., Ehring, B., Tampe, R., and Huber, C. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression. Clin. Cancer Res., 2: 1427-1433, 1996.
39. Kurokohchi, K., Carrington, M., Mann, D. L., Simonis, T. B., Alexander-Miller, M. A., Feinstone, S. M., Akatsuka, T., and Berzofsky, J. A. Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma. Hepatology, 23: 1181-1188, 1996.
40. Alpan, R. S., Zhang, M., and Pardee, A. B. Cell cycle-dependent expression of TAP1, TAP2, and HLA-B27 messenger RNAs in a human breast cancer cell line. Cancer Res., 56: 4358-4361, 1996.
41. Maeurer, M. J., Gollin, S. M., Martin, D., Swaney, W., Bryant, J., Castelli, C., Robbins, P., Parmiani, G., Storkus, W. J., and Lotze, M. T. Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with down-regulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen. J. Clin. Invest., 98: 1633-1641, 1996.
42. Restifo, N. P., Esquivel, F., Kawakami, Y., Yewdell, J. W., Mule, J. J., Rosenberg, S. A., and Bennink, J. R. Identification of human cancers deficient in antigen processing. J. Exp. Med., 177: 265-272, 1993.
43. Cromme, F. V., van Bommel, P. F. J., Walboomers, J. M. M., Gallee, M. P. W., Stern, P. L., Kenemans, P., Heimerhorst, T. J. M., Stukart, M. J., and Meijer, C. J. L. M. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br. J. Cancer. 69: 1176-1181, 1994.
44. Kaklamanis, L., Townsend, A., Doussis-Anagnostopoulou, I. A., Mortensen, N., Harris, A. L., and Gatter, K. C. Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am. J. Pathol., 145: 505-509, 1994.
45. Kaklamanis, L., Leek, R., Koukourakis, M., Gatter, K. C., and Harris, A. L. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer. Cancer Res., 55: 5191-5194, 1995.
46. Sanda, M. G., Restifo, N. P., Walsh, J. C., Kawakami, Y., Nelson, W. G., Pardoll, D. M., and Simons, J. W. Molecular characterization of defective antigen processing in human prostate cancer. J. Natl. Cancer Inst., 87: 280-285, 1995.
47. Rowe, M., Khanna, R., Jacob, C. A., Argaet, V., Kelly, A., Powis, S., Belich, M., Croom-Carter, D., Lee, S., Burrows, S. R., Trowsdale, J., Moss, D. J., and Rickinson, A. B. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1 : coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur. J. Immunol., 25: 1374-1384, 1995.
48. Seliger, B., Hohne, A., Knuth, A., Bernhard, H., Meyer, T., Tampe, R., Momburg, F., and Huber, C. Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression. Cancer Res., 56: 1756-1760, 1996.
49. Cromme, F. V., Airey, J., Heemels, M-T., Ploegh, H. L., Keating, P. J., Stern, P. L., Meijer, C. J. L. M., and Walboomers, J. M. M. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas, J. Exp. Med., 179: 335-340, 1994.
50. Kuroda, K., Yamashina, K., Kitatani, N., Kagishima, A., Hamaoka, T., and Hosaka, Y. Characterization of defectiveness in endogenous antigen presentation of novel murine cells established from methylcholanthrene-induced fibrosarcomas. Immunology, 84: 153-258, 1995.
51. Sibille, C., Gould, K. G., Willard-Gallo, K., Thomson, S., Rivett, A. J., Powis, S., Butcher, G. W., and Baetselier, P. D. LMP2+ proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes. Curr. Biol., 5; 923-930, 1995.
52. Salter, R. D., Howell, D. N., and Cresswell, P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids, Immunogenetics, 21: 235-246, 1985.
53. Salter, R. D., and Cresswell, P. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J., 5: 943-949, 1986.
54. DeMars, R., Rudersdorf, R., Chang, C., Petersen, J., Strandtmann, J., Korn, N., Sidwell, B., and Orr, H. T. Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens. Proc. Natl. Acad. Sci. USA, 82: 8183-8187, 1985.
55. Beck, S., Abdulla, S., Alderton, R. P., Glynne, R. J., Gut, I. G., Hosking, L. K., Jackson, A., Kelly, A., Newell, W. R., Sanseau, P., Radley, E., Thorpe, K. L., and Trowsdale, J. Evolutionary dynamics of non-coding sequences within the class II region of the human MHC. J. Mol. Biol., 255: 1-13, 1996.
56. Thor Straten, P., Kirkin, A. F., Seremet, T., and Zeuthen, J. Expression of transporter associated with antigen processing I and 2 (TAP1/2) in malignant melanoma cell lines. Int. J. Cancer, 70: 582-586, 1997.
57. Campbell, R. D., and Trowsdale, J. Map of the human MHC. Immunol. Today, 14: 349-352, 1993.
58. Wright, K. L., White, L. C, Kelly, A., Beck, S., Trowsdale, J., and Ting, J. P-Y. Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J. Exp. Med., 181: 1459-1471, 1995.
59. Blanchet, O., Bourge, J-F., Zinszner, H., Israel, A., Kourilsky, P., Dausset, J., Degos, L., and Paul, P. Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression. Proc. Natl. Acad. Sci. USA, 89: 3488-3492, 1992.
60. Salcedo, M., Momburg, F., Hammerling, G. J., and Ljunggren, H-G. Resistance to natural killer cell lysis conferred by TAP1/2 genes in human antigen-processing mutant cells. J. Immunol., 152: 1702-1708, 1994.
61. Franksson, L., George, E., Powis, S., Butcher, G., Howard, J., and Karre, K. Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene. J. Exp. Med., 177: 201-205, 1993.